Avricore Health (AVCRF) Cash from Operations (2014 - 2025)
Avricore Health (AVCRF) reported Cash from Operations of 358560.22 for Q3 2025, down 174.35% year-over-year from 482253.11 in Q3 2024, and down 163.93% quarter-over-quarter from 135853.72 in Q2 2025.
Avricore Health (AVCRF) Cash from Operations (2014 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 12 years of Cash from Operations data on file, last reported at 358560.22 in Q3 2025.
- Cash from Operations for Q3 2025 came in at 358560.22, down 174.35% year-over-year; the trailing twelve-month figure through Sep 2025 was 140771.22 (down 88.92% YoY), and the FY2025 annual result was 565371.98, down 177.05% from the prior year.
- Cash from Operations fell to 358560.22 in Q3 2025 per AVCRF's latest filing, from 135853.72 in the prior quarter.
- Over five years, Cash from Operations peaked at 482253.11 in Q3 2024 and troughed at 358560.22 in Q3 2025.
- A 5-year average of 5164.32 and a median of 1341.79 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations jumped 1118.76% in 2023, then sank 174.35% in 2025.
- A 5-year view of Cash from Operations shows it stood at 217428.03 in 2021, then jumped by 91.78% to 17881.25 in 2022, then jumped by 1118.76% to 182167.01 in 2023, then soared by 164.73% to 482253.11 in 2024, then slumped by 174.35% to 358560.22 in 2025.
- Business Quant data shows AVCRF's Cash from Operations at 358560.22 in Q3 2025, 135853.72 in Q2 2025, and 152932.05 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -3.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.19 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.32 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 266.25 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 277.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 40.17 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 618.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 289.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 139.79 Mn |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -358,560.22 |
| Sep 30, 2025 | -358,560.22 |
| Jun 30, 2025 | -135,853.72 |
| Jun 30, 2025 | -135,853.72 |
| Mar 31, 2025 | 152,932.05 |
| Mar 31, 2025 | 152,932.05 |
| Sep 30, 2024 | 482,253.11 |
| Sep 30, 2024 | 482,253.11 |
| Jun 30, 2024 | 304,971.88 |
| Jun 30, 2024 | 304,971.88 |
| Mar 31, 2024 | 301,341.00 |
| Mar 31, 2024 | 301,341.00 |
| Dec 31, 2023 | 182,167.01 |
| Dec 31, 2023 | 182,167.01 |
| Sep 30, 2023 | 137,674.89 |
| Sep 30, 2023 | 137,674.89 |
| Jun 30, 2023 | 100,564.36 |
| Jun 30, 2023 | 100,564.36 |
| Mar 31, 2023 | 68,604.62 |
| Mar 31, 2023 | 68,604.62 |